The current findings regarding reduced bFGF, IGF and TGF-β expression on upregulation of miRNA-145-5p indicate that miR-145-5p may influence the TGF-β signaling pathway by suppressing epithelial to mesenchymal transition and tumor growth to bring about inhibition of bone metastasis. The gene discussed is FGF2; the disease is neoplasm.